CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Atrial fibrillation - Management
Which rate-limiting calcium-channel blocker should I use?
- Diltiazem (off-label) or verapamil (standard release) may be used to treat atrial fibrillation. Diltiazem is preferred because verapamil causes a negative inotropic effect (decrease in myocardial contractility) and interacts with digoxin.
Basis for recommendation
© NHS Institute for Innovation and Improvement